Guru Ownership Trend
Guru Analysis for Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 11 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $985.4 M.
Top institutional holders include Cliff Asness and Mason Hawkins.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $34.78 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 635.5%. Conversely, Steven Cohen reduced exposure by 99.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Regeneron Pharmaceuticals, Inc. (REGN)
Major holders include Cliff Asness ($946.01 M), Mason Hawkins ($100.95 M), Joel Greenblatt ($64.01 M). According to the latest reported data, 11 tracked investment managers collectively hold approximately 1.61 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $34.78 M, with 5 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited REGN. The total reported sell value was $268.11 M.
Yes, 0 managers opened new positions in REGN, and 5 increased their existing holdings. The total reported buy value was $233.33 M.
